Clinical Trial Update: Multi-Center Study of ManNAc for GNE Myopathy [Phase 2]

View source ↗

Summary

A Phase 2 multi-center trial evaluating ManNAc for GNE myopathy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gne Myopathy

Drugs mentioned

• ManNAc (N-acetylmannosamine)

Snippet

Sponsor: Leadiant Biosciences, Inc. | Conditions: GNE Myopathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING